Wolverine Trading
TARA icon

Wolverine Trading’s Protara Therapeutics TARA Stock Holding History

Wolverine Trading’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,700
Closed -$42.9K – 5193
2024
Q1 		$42.9K Buy
+10,700
New +$34.5K ﹤0.01% 4242

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Wolverine Trading's TARA Position: Q3 2025 in Review

Wolverine Trading reduced its Protara Therapeutics (TARA) stake by 8% in Q3 2025, selling an estimated $3.26K and leaving 11,636 shares worth $51.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5407.

Wolverine Trading first reported a position in TARA in Q2 2025 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold TARA as of Q3 2025.

  • Wolverine Trading held 11,636 shares of Protara Therapeutics worth $51.3K as of Q3 2025.
  • Wolverine Trading sold 1,007 Protara Therapeutics shares in Q3 2025, an estimated $3.26K.
  • Protara Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5407 holding.
  • Wolverine Trading first reported a position in Protara Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.